Abstract
Histone deacetylase (HDAC) inhibition modulates dendritic cell (DC) functions and regulates experimental graft-vs-host disease and other immune-mediated diseases. The mechanisms by which HDAC inhibition modulates immune responses remain largely unknown. STAT-3 is a transcription factor shown to negatively regulate DC functions. In this study we report that HDAC inhibition acetylates and activates STAT-3, which regulates DCs by promoting the transcription of IDO. These findings demonstrate a novel functional role for posttranslational modification of STAT-3 through acetylation and provide mechanistic insights into HDAC inhibition-mediated immunoregulation by induction of IDO.
Publication types
-
Research Support, N.I.H., Extramural
MeSH terms
-
Acetylation
-
Animals
-
Blotting, Western
-
Dendritic Cells / immunology
-
Dendritic Cells / metabolism*
-
Enzyme Inhibitors / pharmacology
-
Enzyme-Linked Immunosorbent Assay
-
Histone Deacetylase Inhibitors*
-
Histone Deacetylases / drug effects
-
Immunoprecipitation
-
Indoleamine-Pyrrole 2,3,-Dioxygenase / immunology
-
Indoleamine-Pyrrole 2,3,-Dioxygenase / metabolism*
-
Mice
-
Mice, Inbred C57BL
-
Oligonucleotide Array Sequence Analysis
-
Protein Processing, Post-Translational* / drug effects
-
Reverse Transcriptase Polymerase Chain Reaction
-
STAT3 Transcription Factor / immunology
-
STAT3 Transcription Factor / metabolism*
Substances
-
Enzyme Inhibitors
-
Histone Deacetylase Inhibitors
-
Indoleamine-Pyrrole 2,3,-Dioxygenase
-
STAT3 Transcription Factor
-
Histone Deacetylases